The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: a pilot study. (Q51736261)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 May 2014

Language	Label	Description	Also known as
English	The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: a pilot study.	scientific article published on 12 May 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: a pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

based on heuristic

inferred from title

relapsed neuroblastoma

1 reference

based on heuristic

inferred from title

Ahmad Reza Shamshiri

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Amir Ali Hamidieh

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Pedram Paragomi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Babak Fallahi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Maryam Behfar

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Armaghan Fard-Esfahani

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Ashraf Sadat Hosseini

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Mohammad Eftekhari

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Ardeshir Ghavamzadeh

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

publication date

12 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Pediatric Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

510-517

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24814429%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Neuroblastoma and other neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Targeted Radiotherapy With Submyeloablative Doses of 131I-MIBG Is Effective for Disease Palliation in Highly Refractory Neuroblastoma

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Treatment of advanced neuroblastoma with I-131 meta-iodobenzylguanidine

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma.

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Trends in nuclear medicine in developing countries.

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system.

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Neuroblastoma: issues in transplantation

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Treatment of High-Risk Neuroblastoma With Triple-Tandem High-Dose Therapy and Stem-Cell Rescue: Results of the Chicago Pilot II Study

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12271

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51736261&oldid=1529005648"